Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App




Beckman Coulter and hc1.com Enter Strategic Partnership for Innovative Healthcare Cloud System

By LabMedica International staff writers
Posted on 17 Apr 2014
The diagnostics division of Beckman Coulter (Brea, CA, USA) and hc1.com (Indianapolis, IN, USA) have announced a partnership to bring an innovative healthcare cloud-technology system to clinical laboratories. More...
The system, hc1.com's "Healthcare Relationship Cloud," helps turn large amounts of clinical data into actionable insights that transform how laboratories manage their business and their contributions to improving healthcare. It is used in optimizing the way laboratories, radiology groups, and health systems manage their provider and patient experience across the continuum of care. A winner of the 2013 Red Herring Top 100 Global award, hc1.com is in use worldwide across 500 healthcare locations.

This hc1.com software solution helps laboratories gain real-time visibility into key metrics, including test turnaround time (TAT), test utilization by provider, and productivity per lab operator. Additionally, the solution helps to identify important issues that require immediate action, as well as alert laboratory management to issues that are most prevalent across the entire health system

The partnership creates a powerful solution for clinical laboratories by combining hc1.com’s Software-as-a-Service Healthcare Relationship Cloud with Beckman Coulter’s clinical diagnostic systems. Beckman Coulter will offer hc1.com as its exclusive healthcare relationship management solution to help laboratories in North America manage their critical business and healthcare needs more proactively and with greater intelligence.

“The partnership between Beckman Coulter and hc1.com combines two highly complementary innovators to create value that can revolutionize the healthcare industry,” said Brad Bostic, chairman and CEO, hc1.com; “The agreement will allow Beckman Coulter’s customers to transform the healthcare experience by immediately addressing important provider needs, taking action on those needs, and ultimately delivering an amazing healthcare experience to patients and providers.”

“By leveraging hc1.com’s powerful software cloud solution, laboratories will be able to utilize and interpret more data than ever before to deliver a high level of performance to patients and providers,” said Arnd Kaldowski, president, Beckman Coulter Diagnostics. “Innovative solutions and offerings such as these demonstrate our strong commitment to helping laboratories address challenges while maintaining focus on improving patient outcomes.”

Related Links:

Beckman Coulter Diagnostics
hc1.com



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.